Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jing-rong Weng"'
Autor:
Yu-ming Rong, Yu-cheng Xu, Xiao-chuan Chen, Min-er Zhong, Ying-xin Tan, Yu-fan Liang, Jing-rong Weng, Jun Liu, Xin-you Wang, Dan-dong Luo, Yi-ran Bie, Xi Chen, Jia-wei Cai, Zhao-liang Yu, Yi-feng Zou
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Immunotherapy has dramatically changed the landscape of treatment for colorectal cancer (CRC), but currently lack of effective predictive biomarker, especially for tumors with mismatch repair (MMR) proficiency. The response of immunotherapy
Externí odkaz:
https://doaj.org/article/10fbb90a84fc4f659197f899133e2af7
Autor:
Xu-tao Lin, Qiu-ning Wu, Si Qin, De-jun Fan, Min-yi Lv, Xi Chen, Jia-wei Cai, Jing-rong Weng, Yi-feng Zou, Yu-ming Rong, Feng Gao
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Purpose: A certain number of early-stage colorectal cancer (CRC) patients suffer tumor recurrence after initial curative resection. In this context, an effective prognostic biomarker model is constantly in need. Autophagy exhibits a dual role in tumo
Externí odkaz:
https://doaj.org/article/2be0498ee9e34a008809051b7a3d9a29
Autor:
Yu-cheng Xu, Zhao-liang Yu, Xiao-chuan Chen, Min-er Zhong, Yu-fan Liang, Jing-rong Weng, Dan-dong Luo, Yi-ran Bie, Xi Chen, Jia-wei Cai, Yu-ming Rong, Yi-feng Zou
Background：Immunotherapy has dramatically changed the landscape of treatment for colorectal cancer (CRC), but there is lack of effective predictive biomarker, especially for tumors with mismatch repair (MMR) proficiency. Immune response relies to c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db197376c96bcfefe62f9c5e7c4fa167
https://doi.org/10.21203/rs.3.rs-2194686/v1
https://doi.org/10.21203/rs.3.rs-2194686/v1
Autor:
Xutao Lin, Yu-ming Rong, Zexian Chen, Jing-rong Weng, Ying-xin Tan, Zhi-hong Shen, Yifeng Zou, Xi Chen, Xiaoming Huang
Publikováno v:
OncoTargets and Therapy. 13:8691-8704
Background Huaier extract has been a part of traditional Chinese medicine (TCM) for roughly 1600 years and may serve as a potential anti-cancer drug as it is associated with good efficacy and low toxicity. Individuals with inflammatory bowel disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5163a1d3ef4d2ade665831440227bfac
https://doi.org/10.2147/ott.s253598
https://doi.org/10.2147/ott.s253598
Autor:
Xinzhi Zhang, Jia-wei Cai, Zhi-hong Shen, Yu-ming Rong, Ying-xin Tan, Yifeng Zou, Jing-rong Weng, Xutao Lin, Xi Chen
Publikováno v:
International Journal of Hyperthermia, Vol 37, Iss 1, Pp 944-954 (2020)
Background The optimal treatment for colorectal cancer (CRC) with synchronous peritoneal carcinomatosis (PC) and liver metastases (LM) remains controversial. We aimed to investigate clinical outcomes in patients with CRC and concomitant PC and LM who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::073898735cd4259093fb1a28165679e5
https://doi.org/10.1080/02656736.2020.1803424
https://doi.org/10.1080/02656736.2020.1803424
Autor:
Ping Lan, Xutao Lin, Lixin Zhu, Jie Li, Yufan Liang, Yibo Huang, Sijing Cheng, Lihan Shen, Yifeng Zou, Guangjun Yan, Yichen Li, Jing-rong Weng, Ruixin Zhu, Na Jiao
Publikováno v:
The Lancet. Gastroenterology & Hepatology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e1e6549e4cf23512650c598ccd3504e
https://doi.org/10.1016/s2468-1253(21)00076-5
https://doi.org/10.1016/s2468-1253(21)00076-5
Autor:
Lixin Zhu, Ruixin Zhu, Xutao Lin, Jie Li, Jing-rong Weng, Yibo Huang, Na Jiao, Yichen Li, Ping Lan, Yifeng Zou, Sijing Cheng, Lihan Shen, Guangjun Yan, Yufan Liang
Publikováno v:
SSRN Electronic Journal.
Background: The majority of COVID-19 patients presented persisting symptoms after discharge. We aimed to determine the long-term enteric consequences of SARS-CoV-2 infection, and to identify the risk and the protective factors for gastrointestinal se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::480608f8e83c5d82102973dd05470718
https://doi.org/10.2139/ssrn.3786714
https://doi.org/10.2139/ssrn.3786714
Autor:
Xi Xi Chen, Yi-feng Zou, Qiu-ning Wu, Ying-xin Tan, Jia-wei Cai, Jing-rong Weng, Si Qin, Xu-tao Lin, Yu-ming Rong
Background and aimsA certain number of early-stage colorectal cancer (CRC) patients suffer tumor recurrence after initial curative resection. In this context, an effective prognostic biomarker model is constantly in need. Autophagy exhibits a dual ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ba2a35c2a7fcdfad0b8e8e04140d40c
https://doi.org/10.21203/rs.3.rs-59367/v1
https://doi.org/10.21203/rs.3.rs-59367/v1
Autor:
Xiao-Lan Li, Xi Chen, Xiaoming Huang, Yifeng Zou, Si Qin, Xutao Lin, Jing-rong Weng, Jia-wei Cai, Yu-ming Rong
Publikováno v:
Gastroenterology Report
Background Prognosis varies among patients within the same colon adenocarcinoma (COAD) stage, indicating the need for reliable molecular markers to enable individualized treatment. This study aimed to investigate gene signatures that can be used for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5de0f9e96e304145fbc6e2acaefd80c
https://pubmed.ncbi.nlm.nih.gov/34733531
https://pubmed.ncbi.nlm.nih.gov/34733531
Autor:
Yi-Feng, Zou, Yu-Ming, Rong, Ze-Xian, Chen, Zhi-Hong, Shen, Xi, Chen, Ying-Xin, Tan, Jing-Rong, Weng, Xiao-Ming, Huang, Xu-Tao, Lin
Publikováno v:
OncoTargets and therapy
Background Huaier extract has been a part of traditional Chinese medicine (TCM) for roughly 1600 years and may serve as a potential anti-cancer drug as it is associated with good efficacy and low toxicity. Individuals with inflammatory bowel disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1dfbff3b44cf47f72add59fedbbb8543
https://pubmed.ncbi.nlm.nih.gov/32904640
https://pubmed.ncbi.nlm.nih.gov/32904640